Arbutus Biopharma Corp
USD4.79
+0.12 (+2.46%)
CEO
Lindsay Androski
IPO Date
2007-07-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.70
Prev. Close
$4.68
Day Low
$4.67
Day High
$4.87
52W Low
$3.06
52W High
$5.10
Market Cap
$0.95B
Volume
1.76M
| -8.7 |
| 31 Dec 2023 | FY | 100.0% | -401.6% | -68.7% | -50.4% | 0.08 | 5.87 | -5.7 |
| 31 Dec 2022 | FY | 100.0% | -178.0% | -50.8% | -35.5% | 0.09 | 4.60 | -5.1 |
| 31 Dec 2021 | FY | 100.0% | -693.9% | -45.0% | -37.3% | 0.11 | 14.32 | -5.4 |
| 31 Dec 2020 | FY | -586.7% | -922.0% | -62.5% | -46.5% | 0.22 | 13.38 | -4.2 |
| 31 Dec 2019 | FY | -858.3% | -2557.4% | -211.3% | -145.7% | 0.05 | 11.99 | -1.0 |
| 31 Dec 2018 | FY | -881.4% | -967.8% | -28.5% | -25.1% | 0.00 | 11.50 | -3.7 |
| 31 Dec 2017 | FY | -486.0% | -788.8% | -46.2% | -35.6% | 0.07 | 10.87 | -3.3 |
| 31 Dec 2016 | FY | -3986.7% | -25606.7% | -189.2% | -139.2% | 0.06 | 12.51 | -0.3 |
| -61.3 |
| 30 Sept 2025 | Q3 | 97.9% | -1463.5% | -10.0% | -7.9% | 0.01 | 18.80 | -28.1 |
| 30 Jun 2025 | Q2 | 100.0% | 23.5% | 3.0% | 2.4% | 0.01 | 20.53 | 58.6 |
| 31 Mar 2025 | Q1 | -407.9% | -1390.4% | -31.0% | -21.0% | 0.02 | 6.01 | -6.8 |
| 31 Dec 2024 | Q4 | -459.7% | -796.2% | -12.9% | -9.5% | 0.01 | 8.15 | -12.1 |
| 30 Sept 2024 | Q3 | 100.0% | -1472.5% | -18.4% | -14.0% | 0.06 | 7.02 | -9.2 |
| 30 Jun 2024 | Q2 | 100.0% | -1146.9% | -16.2% | -12.4% | 0.06 | 6.56 | -7.4 |
| 31 Mar 2024 | Q1 | 100.0% | -1166.8% | -15.6% | -11.9% | 0.07 | 6.69 | -6.3 |
| 31 Dec 2023 | Q4 | -718.8% | -900.3% | -18.2% | -13.4% | 0.08 | 5.87 | -5.5 |